MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-08-0007768
Satyam Drugs Private Limited
Satyam Drugs Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2022
₹1.39 Cr
▼ 71% YoY
Net profit · FY 2022
₹35,832
Net margin 0.3%
EBITDA · FY 2022
₹23.16 Lakh
EBITDA margin 16.7%
Authorised capital
₹1.5 Cr
Registered with MCA
Paid-up capital
₹1.5 Cr
Issued & subscribed
Open charges
₹2.67 Cr
Secured borrowings
Company age
11 yrs
Est. 2015
Directors on board
2
As per MCA filings
About Satyam Drugs Private Limited
Data last updated:
Satyam Drugs Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 12 October 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2015PTC286345. Its GSTIN is 07AAWCS3309K1ZT (Delhi). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1.5 Cr and a paid-up capital of ₹1.5 Cr. It is led by directors Raj Kumar Garg and Lokesh Kumar.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at B – 155 Ground Floor Dda Shed Okhla Phase – 1, New Delhi, Delhi, India – 110020.
As per the financials filed for FY 2022, the company reported a revenue of ₹1.39 Cr, a decline of 71% compared to the previous year. For the same year it recorded a net profit of ₹35,832 (net margin 0.3%) and EBITDA of ₹23.16 Lakh (EBITDA margin 16.7%). Revenue has declined at a compounded annual rate (CAGR) of 57% over three years and 41% over five years.
As per MCA filings, the company has open charges of ₹2.67 Cr on record. Court records list 25 cases involving the company, including 25 filed against it; 8 cases are pending.
Satyam Drugs Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-08-0007768). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U51909DL2015PTC286345
Registration Number 286345
Incorporation Date 12 October 2015
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2022
Date of Balance Sheet 31 March 2022
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-08-0007768
Key People
Raj Kumar Garg Director Lokesh Kumar Director Recognitions & Rankings of Satyam Drugs
Contact details
Satyam Drugs Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressB – 155 Ground Floor Dda Shed Okhla Phase – 1, New Delhi, Delhi, India – 110020
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Satyam Drugs Private Limited, buy the company report.
Comprehensive company report
Satyam Drugs Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Satyam Drugs is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Satyam Drugs Private Limited, buy the company report.
Financials of Satyam Drugs Private Limited
FY 2022 filings availableSatyam Drugs Private Limited reported revenue of ₹1.39 Cr (down 71% YoY) for FY 2022.
Revenue · FY 2022
₹1.39 Cr ▼ 71%
Net profit · FY 2022
₹35,832 margin 0.3%
EBITDA · FY 2022
₹23.16 Lakh margin 16.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 71%
3 years · compounded
▼ 57%
5 years · compounded
▼ 41%
EBITDA CAGR growth
1 year
▼ 11%
3 years · compounded
▼ 17%
5 years · compounded
▲ 16%
Revenue has declined at a compounded annual rate (CAGR) of 41% over five years, including a 71% fall in the latest year. EBITDA fell 11% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹1.39 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹23.16 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹35,832 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 16.7% | ||||
| Net Profit Margin | 0.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Satyam Drugs Private Limited, buy the company report.
Board of directors of Satyam Drugs Private Limited
Satyam Drugs has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Raj Kumar Garg | Director | 12 Oct 2015 | 11 Years 0 Months | Current |
| Lokesh Kumar Also directs: Meditronics Healthcare Solutions Private Limited | Director | 24 Nov 2021 | 4 Years 11 Months | Current |
Peer comparison
Satyam Drugs Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Rhythm Pharma India Private Limited | ₹1.39 Cr (FY 2016) | -28.0% | Salem, Tamil Nadu, India | |||
| Clyde Biotech Private Limited | ₹1.39 Cr (FY 2019) | -2.0% | Patna, Bihar, India | |||
| Satyam Drugs Private Limitedthis company | ₹1.39 Cr (FY 2022) | ₹35,832 | 0.3% | -71.0% | New Delhi, Delhi, India | |
| Miral Health Care Private Limited | ₹1.39 Cr (FY 2024) | -4.0% | Lucknow, Uttar Pradesh, India | |||
| Derma Land Private Limited | ₹1.38 Cr (FY 2025) | 78.0% | New Delhi, Delhi, India |
To see the full peer comparison of Satyam Drugs Private Limited, buy the company report.
Auditor
Satyam Drugs Private Limited is audited by S H R P & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S H R P & ASSOCIATES | FY 2022 | 020515N |
Shareholding
The shareholding of Satyam Drugs Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Satyam Drugs Private Limited, buy the company report.
Charges & borrowings
Open charges
₹2.67 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Aug 2017 | 100134635 | Hdfc Bank Limited | ₹2.67 Cr | Open |
To see the full charge records of Satyam Drugs Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
Satyam Drugs Private Limited has 25 court cases on record: 25 filed against it. 8 cases are pending and 17 are disposed.
Total cases
25
Filed against the company
25
Pending
8
Disposed
17
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 16 | 16 | 7 |
| Supreme Court | 8 | 8 | 0 |
| NCLAT | 1 | 1 | 1 |
Cases on record (5 of 25)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary case) | Filed against the company by Bayer Zydus Pharma Pvt Ltd Through Mr Sandeep Gaonkar | Pending |
| District court, New Delhi, Delhi | Criminal case | Filed against the company by Health Care at Home India Pvt Ltd | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (SUMMARY CASE) | Filed against the company by Bayer Zydus Pharma Pvt Ltd Through Mr Sandeep Gaonkar | Disposed |
| District court, South, Delhi | Cheque dishonour complaint | Filed against the company by RBL Bank Ltd | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Court case (S S) | Filed against the company by Bayer Zydus Pharma Pvt. Ltd. | Disposed |
To see the full case history of Satyam Drugs Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Satyam Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Satyam Drugs has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAWCS3309K1ZT | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Satyam Drugs Private Limited, buy the company report.
Recent activity
Satyam Drugs Private Limited has 3 board changes on record since 2015: 2 appointments and 1 cessation. The latest: Lokesh Kumar was appointed as Director on 24 Nov 2021.
AGM
Satyam Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records.
Filing
Satyam Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Delhi.
Appointed
Lokesh Kumar was appointed as Director.
Ceased
Hitesh Verma ceased to be Director.
Charges
A charge with Hdfc Bank Limited of Rs. 2.67 Cr registered on 27 Aug 2017 with Charge ID 100134635 was modified on 20 Mar 2021.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 2.67 Cr with Charge ID 100134635 was registered on 27 Aug 2017.
Appointed
Raj Kumar Garg was appointed as Director.
Incorporation
12 Oct 2015
Satyam Drugs Private Limited was registered on 12 Oct 2015 with Roc Delhi & aged 11 years 27 days as per MCA records.
Frequently asked questions
Satyam Drugs is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 12 October 2015 (11+ years old) and is registered under CIN U51909DL2015PTC286345.
Satyam Drugs has 2 current directors:
- Raj Kumar Garg - Director
- Lokesh Kumar - Director
The latest financial statements of Satyam Drugs on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Satyam Drugs is 07AAWCS3309K1ZT, registered in Delhi. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Satyam Drugs is U51909DL2015PTC286345. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Satyam Drugs has 25 court cases on record: 25 filed against it. 8 are pending. Most are in the district courts.
Satyam Drugs was incorporated on 12 October 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Satyam Drugs by revenue are Rhythm Pharma India Private Limited, Clyde Biotech Private Limited, Miral Health Care Private Limited, Derma Land Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Lokesh Kumar was appointed as Director on 24 Nov 2021. Hitesh Verma ceased to be Director on 05 Nov 2021. Raj Kumar Garg was appointed as Director on 12 Oct 2015.
Yes, Satyam Drugs is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-08-0007768).
The registered office of Satyam Drugs is at B – 155 Ground Floor Dda Shed Okhla Phase – 1, New Delhi, Delhi, India – 110020.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages